Rep. April McClain Delaney Acquires BWX Technologies, Inc. (NYSE:BWXT) Shares

Representative April McClain Delaney (Democratic-Maryland) recently bought shares of BWX Technologies, Inc. (NYSE:BWXT). In a filing disclosed on August 03rd, the Representative disclosed that they had bought between $1,001 and $15,000 in BWX Technologies stock on July 27th.

Representative April McClain Delaney also recently made the following trade(s):

• Purchased $15,001 – $50,000 in shares of Life Time Group (NYSE:LTH) on 7/31/2026.
• Purchased $15,001 – $50,000 in shares of Liberty Media Corporation – Liberty Formula One Series C (NASDAQ:FWONK) on 7/31/2026.
• Sold $1,001 – $15,000 in shares of Corpay (NYSE:CPAY) on 7/31/2026.
• Purchased $15,001 – $50,000 in shares of C.H. Robinson Worldwide (NASDAQ:CHRW) on 7/31/2026.
• Sold $1,001 – $15,000 in shares of STERIS (NYSE:STE) on 7/31/2026.
• Purchased $15,001 – $50,000 in shares of Somnigroup International (NYSE:SGI) on 7/30/2026.
• Purchased $1,001 – $15,000 in shares of Entegris (NASDAQ:ENTG) on 7/30/2026.
• Sold $1,001 – $15,000 in shares of Corpay (NYSE:CPAY) on 7/30/2026.
• Purchased $1,001 – $15,000 in shares of Life Time Group (NYSE:LTH) on 7/30/2026.
• Sold $1,001 – $15,000 in shares of Service Corporation International (NYSE:SCI) on 7/30/2026.

BWX Technologies Stock Performance

BWX Technologies stock opened at $172.19 on Wednesday. The firm has a 50 day simple moving average of $186.82 and a 200-day simple moving average of $201.30. The stock has a market cap of $15.77 billion, a price-to-earnings ratio of 46.04, a price-to-earnings-growth ratio of 2.96 and a beta of 0.76. The company has a debt-to-equity ratio of 1.58, a current ratio of 2.40 and a quick ratio of 2.33. BWX Technologies, Inc. has a 1-year low of $157.10 and a 1-year high of $241.82.

BWX Technologies (NYSE:BWXT) last released its quarterly earnings results on Monday, August 3rd. The technology company reported $1.07 EPS for the quarter, beating the consensus estimate of $1.04 by $0.03. The firm had revenue of $901.62 million for the quarter, compared to analyst estimates of $902.41 million. BWX Technologies had a net margin of 10.11% and a return on equity of 31.34%. The business’s revenue for the quarter was up 18.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.02 EPS. BWX Technologies has set its FY 2026 guidance at 4.700-4.800 EPS. On average, analysts expect that BWX Technologies, Inc. will post 4.61 EPS for the current year.

BWX Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, September 4th. Stockholders of record on Tuesday, August 18th will be paid a $0.27 dividend. The ex-dividend date of this dividend is Tuesday, August 18th. This represents a $1.08 annualized dividend and a dividend yield of 0.6%. BWX Technologies’s dividend payout ratio is 28.88%.

Insider Transactions at BWX Technologies

In related news, CEO Rex D. Geveden sold 10,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $204.81, for a total transaction of $2,048,100.00. Following the sale, the chief executive officer directly owned 202,491 shares in the company, valued at approximately $41,472,181.71. This represents a 4.71% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Michael Thomas Fitzgerald sold 2,417 shares of the firm’s stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $209.25, for a total transaction of $505,757.25. Following the completion of the sale, the chief financial officer directly owned 6,884 shares in the company, valued at approximately $1,440,477. This trade represents a 25.99% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 0.60% of the company’s stock.

BWX Technologies News Roundup

Here are the key news stories impacting BWX Technologies this week:

• Positive Sentiment: BWXT reported second-quarter EPS of $1.07, exceeding the $1.04 consensus estimate, while revenue increased 18% year over year to approximately $901.6 million. Strong execution and commercial operations growth supported management’s more optimistic outlook. BWXT Reports Second Quarter 2026 Results
• Positive Sentiment: Management raised 2026 adjusted EPS guidance to $4.70-$4.80 and increased free-cash-flow guidance to $345 million-$360 million. The improved outlook reflects stronger operations and reinforces the company’s earnings and cash-generation prospects. BWXT Raises EPS and Free Cash Flow Outlook
• Positive Sentiment: BWXT agreed to sell its medical business to Nordic Capital in a transaction valued at up to $800 million, while retaining a minority stake. The divestiture should provide liquidity for expansion in nuclear components, naval propulsion, and small modular reactors, creating a more focused nuclear and defense profile. BWXT Medical Business Sale
• Positive Sentiment: BTIG reaffirmed a Buy rating with a $235 price target, while Northland Securities modestly increased its FY2026 and FY2027 EPS forecasts to $4.71 and $5.17, respectively. These revisions suggest analysts see additional earnings growth ahead.
• Neutral Sentiment: BWXT maintained its quarterly dividend at $0.27 per share, payable September 4, with an ex-dividend date of August 18. The roughly 0.6% yield provides a modest shareholder return but is unlikely to be a major valuation driver.
• Negative Sentiment: Northland cut its Q3 2026 EPS estimate to $1.18 from $1.22, indicating some expected near-term variability. BWXT also trades at a relatively high valuation, with a P/E near 46, leaving the stock sensitive to execution issues, delayed reactor projects, regulatory hurdles, or pressure on margins during capacity expansion.

Analysts Set New Price Targets

Several research analysts have weighed in on BWXT shares. Wall Street Zen raised shares of BWX Technologies from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Zacks Research lowered shares of BWX Technologies from a “strong-buy” rating to a “hold” rating in a report on Monday, May 11th. Truist Financial increased their price objective on shares of BWX Technologies from $205.00 to $212.00 and gave the stock a “hold” rating in a research report on Monday, May 11th. Seaport Research Partners raised BWX Technologies from a “neutral” rating to a “buy” rating and set a $245.00 target price on the stock in a research report on Monday, June 22nd. Finally, BTIG Research restated a “buy” rating and set a $235.00 price target on shares of BWX Technologies in a research note on Tuesday. Two equities research analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $228.20.

Institutional Trading of BWX Technologies

Hedge funds have recently modified their holdings of the stock. Invesco Ltd. boosted its holdings in BWX Technologies by 0.7% in the fourth quarter. Invesco Ltd. now owns 2,568,117 shares of the technology company’s stock valued at $443,873,000 after purchasing an additional 18,967 shares during the period. Franklin Resources Inc. raised its position in BWX Technologies by 2.4% in the 4th quarter. Franklin Resources Inc. now owns 2,258,282 shares of the technology company’s stock valued at $390,321,000 after purchasing an additional 53,594 shares in the last quarter. Geode Capital Management LLC raised its position in BWX Technologies by 3.9% in the 4th quarter. Geode Capital Management LLC now owns 1,857,716 shares of the technology company’s stock valued at $321,176,000 after purchasing an additional 69,857 shares in the last quarter. Blair William & Co. IL boosted its stake in shares of BWX Technologies by 20.9% in the 4th quarter. Blair William & Co. IL now owns 1,439,666 shares of the technology company’s stock valued at $248,832,000 after buying an additional 248,598 shares during the period. Finally, First Trust Advisors LP boosted its stake in shares of BWX Technologies by 12.2% in the 1st quarter. First Trust Advisors LP now owns 1,391,079 shares of the technology company’s stock valued at $284,462,000 after buying an additional 151,580 shares during the period. 94.39% of the stock is currently owned by institutional investors and hedge funds.

About Representative McClain Delaney

April McClain-Delaney (Democratic Party) is a member of the U.S. House, representing Maryland’s 6th Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.

McClain-Delaney (Democratic Party) is running for re-election to the U.S. House to represent Maryland’s 6th Congressional District. She declared candidacy for the 2026 election.

April McClain-Delaney grew up in Buhl, Idaho, where her father was a potato farmer. She obtained her bachelor’s degree in communications from Northwestern University in 1986 and her law degree from Georgetown Law Center in 1989. McClain-Delaney worked in communications law, first with the satellite firm Orion Network Systems and later as the Washington director for Common Sense Media, a nonprofit focused on technology and children. In 2022, McClain-Delaney joined the U.S. Department of Commerce under President Joe Biden (D) as deputy assistant secretary for communications and information. McClain-Delaney served on the board of the Georgetown University Law Center, the International Center for Research on Women, and the Northwestern University School of Communications.

About BWX Technologies

BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.